Shandong Xinhua Pharmaceutical Company Limited (000756.SZ)

CNY 15.85

(0.38%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 8.35 Billion 8.26 Billion 7.33 Billion 7.09 Billion 6.43 Billion 5.91 Billion
Total Current Assets 3.31 Billion 3.45 Billion 2.75 Billion 2.68 Billion 2.42 Billion 2.34 Billion
Cash And Short Term Investments 918.33 Million 1.15 Billion 744.66 Million 855.77 Million 690.46 Million 778.42 Million
Cash and Cash Equivalents 918.33 Million 1.15 Billion 744.66 Million 855.77 Million 690.46 Million 778.42 Million
Short Term Investments - -48.35 Million -56.3 Million -61.93 Million -72.81 Million -69.36 Million
Net Receivables 1.01 Billion 1.03 Billion 937.16 Million 592.66 Million 504.68 Million 545.31 Million
Inventory 1.31 Billion 1.21 Billion 1.02 Billion 1.12 Billion 1.13 Billion 951.72 Million
Other Current Assets 65.9 Million 50.79 Million 44.59 Million 114.06 Million 102.89 Million 73.69 Million
Total Non-Current Assets 5.04 Billion 4.8 Billion 4.57 Billion 4.4 Billion 4 Billion 3.56 Billion
Net PPE 4.08 Billion 4 Billion 3.76 Billion 3.53 Billion 3.2 Billion 2.88 Billion
Good Will And Intangible Assets 494.93 Million 474.1 Million 466.45 Million 449.24 Million 411.59 Million 332.7 Million
Good Will - - - - - -
Intangible Assets 494.93 Million 474.1 Million 466.45 Million 449.24 Million 411.59 Million 332.7 Million
Long-Term Investments 275.27 Million 287.53 Million 316.5 Million 378.55 Million 369.05 Million 278.69 Million
Tax Assets 91.64 Million 15.96 Million 15.16 Million 23.51 Million 26 Million 22.24 Million
Other Non Current Assets 95.55 Million 30.1 Million 14.22 Million 15.91 Million 2.00 48.97 Million
Other Assets - 1.00 - 1.00 - 1.00
Total Liabilities 3.45 Billion 3.91 Billion 3.68 Billion 3.7 Billion 3.32 Billion 3.11 Billion
Total Current Liabilities 2.48 Billion 3.15 Billion 2.5 Billion 2.38 Billion 2.48 Billion 2.36 Billion
Account Payables 666.41 Million 1.09 Billion 1.06 Billion 742.9 Million 798.51 Million 889.6 Million
Tax Payables 5.03 Million 33.71 Million 28.24 Million 23.06 Million 19.17 Million 23.62 Million
Short Term Debt 1.07 Billion 835.48 Million 693.27 Million 623.03 Million 888.99 Million 841.63 Million
Deferred Revenue 149.13 Million 593.26 Million 696.61 Million 982.37 Million 449 Million 23.62 Million
Other Current Liabilities 597.27 Million 639.65 Million 45.59 Million 32.72 Million 348.99 Million 605.17 Million
Total Non Current Liabilities 971.91 Million 756.74 Million 1.17 Billion 1.32 Billion 839.98 Million 759.55 Million
Long-Term Debt 799.4 Million 548.37 Million 350.47 Million 464.5 Million 590.63 Million 522.64 Million
Deferred Revenue Non Current 100.66 Million 118.37 Million 132.16 Million 144.69 Million 141.67 Million 128.29 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -95.52 Million 23.56 Million 630.76 Million 642.11 Million 53.84 Million 77.73 Million
Other Liabilities 1.00 - - 1.00 1.00 -
Total Equity 4.77 Billion 4.34 Billion 3.65 Billion 3.39 Billion 3.11 Billion 2.79 Billion
Stock Holders Equity 4.55 Billion 4.12 Billion 3.46 Billion 3.22 Billion 2.96 Billion 2.68 Billion
Common Stock 674.68 Million 669.62 Million 627.36 Million 621.85 Million 621.85 Million 621.85 Million
Retained Earnings 2.3 Billion 1.98 Billion 1.7 Billion 1.47 Billion 1.25 Billion 1.04 Billion
Accumulated other comprehensive income 819.15 Million 744.67 Million 647.11 Million 674.29 Million 644.79 Million 566.72 Million
Common Stock Equity 4.55 Billion 4.12 Billion 3.46 Billion 3.22 Billion 2.96 Billion 2.68 Billion
Capital Lease Obligation 1.57 Million 2.71 Million 4.27 Million 1.76 Million 855.95 Thousand 66.9 Million
Total Investments 275.27 Million 239.18 Million 260.19 Million 316.61 Million 296.24 Million 209.33 Million
Total Debt 1.87 Billion 1.38 Billion 1.04 Billion 1.08 Billion 1.47 Billion 1.36 Billion
Net Debt 955.82 Million 225.11 Million 299.09 Million 231.76 Million 789.16 Million 585.85 Million

Balance Sheet Charts